Search
Descriptor English: CA-19-9 Antigen
Descriptor Spanish: Antígeno CA-19-9
Descriptor antígeno CA-19-9
Entry term(s) 5-acetilneuraminil-2-3-galactosil-1-3-(fucopiranosil-1-4)-N-acetilglucosamina
antígeno del cáncer gastrointestinal
antígeno sialil-Lewis A
sialil-Le(a)
sialil-Lewis A
tetrasacárido sialil-Lewis(a)
Scope note: Antígeno glucídico del grupo sanguíneo Lewis(a) sialilado que se encuentra en muchos adenocarcinomas del tracto digestivo, especialmente en los tumores pancreáticos.
Descriptor Portuguese: Antígeno CA-19-9
Descriptor French: Antigène CA 19-9
Entry term(s): 5-Acetylneuraminyl-2-3-Galactosyl-1-3-(Fucopyranosyl-1-4)-N-Acetylglucosamine
A, Sialyl Lewis
Antigen CA 19 9
Antigen CA-19-9
Antigen, CA 19-9
Antigen, CA 19.9
Antigen, CA-19-9
CA 19 9 Antigen
CA 19-9 Antigen
CA 19.9 Antigen
CA-19-9, Antigen
Cancer Antigen, Gastrointestinal
Gastrointestinal Cancer Antigen
Lewis A, Sialyl
NAG-1,3-F-1,4-GN
Neu5Ac-2-3-Gal-1-3-(Fuc-1-4)-GlcNAc
Sialyl Le(a)
Sialyl Lewis A
Sialyl Lewis A Antigen
Sialyl Lewis(a) Tetrasaccharide
alpha-Neu5Ac-(2-3)-beta-D-Gal-(1-3)-(alpha-L-Fuc-(1-4))-beta-D-GlcNAc
Tree number(s): D23.050.285.050.119
D23.050.301.290.544.119
D23.050.550.325.119
D23.050.705.230.544.119
D23.101.140.075.119
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D018395
Scope note: Sialylated Lewis(a) blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
DE drug effects
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PO poisoning
RE radiation effects
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Previous Indexing: Antigens, Neoplasm (1984-1988)
Antigens, Tumor-Associated, Carbohydrate (1989-1994)
Public MeSH Note: 1995; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-1994; for Sialyl Lewis A see OLIGOSACCHARIDES 1994-2019
History Note: 1995; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-1994; for Sialyl Lewis A use OLIGOSACCHARIDES 1994-2019
DeCS ID: 32325
Unique ID: D018395
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1995/01/01
Date of Entry: 1994/04/16
Revision Date: 2019/05/30
CA-19-9 Antigen - Preferred
Concept UI M0027621
Scope note Sialylated Lewis(a) blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors.
Preferred term CA-19-9 Antigen
Entry term(s) 5-Acetylneuraminyl-2-3-Galactosyl-1-3-(Fucopyranosyl-1-4)-N-Acetylglucosamine
A, Sialyl Lewis
Antigen CA 19 9
Antigen CA-19-9
Antigen, CA 19-9
Antigen, CA 19.9
Antigen, CA-19-9
CA 19 9 Antigen
CA 19-9 Antigen
CA 19.9 Antigen
CA-19-9, Antigen
Cancer Antigen, Gastrointestinal
Gastrointestinal Cancer Antigen
Lewis A, Sialyl
NAG-1,3-F-1,4-GN
Neu5Ac-2-3-Gal-1-3-(Fuc-1-4)-GlcNAc
Sialyl Le(a)
Sialyl Lewis A
Sialyl Lewis A Antigen
Sialyl Lewis(a) Tetrasaccharide
alpha-Neu5Ac-(2-3)-beta-D-Gal-(1-3)-(alpha-L-Fuc-(1-4))-beta-D-GlcNAc



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey